2024 annual report of the European Medicines Agency

ANNUAL REPORT 2024 The European Medicines Agency’s contribution to science, medicines and health in 2024 An agency of the European Union Luxembourg: Publications Office of the European Union, 2025 Print ISBN 978-92-9155-144-6 ISSN 1725-3225 doi:10.2809/4697857 TC-01-25-026-EN-C PDF ISBN 978-92-9155-143-9 ISSN 2467-2106 doi:10.2809/7433636 TC-01-25-026-EN-N HTML ISBN 978-92-9155-142-2 ISSN 2467-2106 doi:10.2809/6143038 TC-01-25-026-EN-Q © European Medicines Agency, 2025 Reproduction is authorised provided the source is acknowledged. For any use or reproduction of photos or other material that is not under the copyright of the European Medicines Agency, permission must be sought directly from the copyright holders. All photographs are copyright protected and have been licenced via either Adobe Stock, Dreamstime or iStockphoto, as shown respectively in the credit lines included in each photograph. Cover image: © joyfotoliakid | stock.adobe.com Chapter 1 image: © stokkete | stock.adobe.com Chapter 2 image: © Lui Shtein | stock.adobe.com Table of contents Foreword by Lorraine Nolan Chair of EMA Management Board 4 Introduction by Emer Cooke EMA Executive Director 6 CHAPTER 1 Key achievements in 2024 9 Evaluation and monitoring of medicines: highlights 12 Better evidence to translate innovation into medicines 20 Regulatory cooperation to improve global health 30 Key activities and events in 2024 38 CHAPTER 2 Key figures in 2024 50 Human...